64L

KB2115

Find entries where: 64L

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	KB2115
Synonyms	3-({3,5-dibromo-4-[4-hydroxy-3-(propan-2-yl)phenoxy]phenyl}amino)-3-oxopropanoic acid
Identifiers	3-[[3,5-bis(bromanyl)-4-(4-oxidanyl-3-propan-2-yl-phenoxy)phenyl]amino]-3-oxidanylidene-propanoic acid
Formula	C₁₈ H₁₇ Br₂ N O₅
Molecular Weight	487.139
Type	NON-POLYMER
Isomeric SMILES	CC(C)c1cc(ccc1O)Oc2c(cc(cc2Br)NC(=O)CC(=O)O)Br
InChI	InChI=1S/C18H17Br2NO5/c1-9(2)12-7-11(3-4-15(12)22)26-18-13(19)5-10(6-14(18)20)21-16(23)8-17(24)25/h3-7,9,22H,8H2,1-2H3,(H,21,23)(H,24,25)
InChIKey	VPCSYAVXDAUHLT-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	43
Chiral Atom Count	0
Bond Count	44
Aromatic Bond Count	12

Drug Info: DrugBank

DrugBank ID	DB05035
Name	Eprotirome
Groups	investigational
Description	Eprotirome which is a compound with promising properties for treatment of obesity and dyslipidemia. Eprotirome increases the body’s energy consumption and reduces body weight and markedly reduces blood lipids and blood glucose.
Synonyms	Eprotirome
Indication	Investigated for use/treatment in hyperlipidemia, metabolic disease, and obesity.
Categories	Amides Amines Aniline Compounds
CAS number	355129-15-6

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Thyroid hormone receptor alpha	MEQKPSKVECGSDPEENSARSPDGKRKRKNGQCSLKTSMSGYIPSYLDKD...	unknown
Thyroid hormone receptor beta	MTPNSMTENGLTAWDKPKHCPDREHDWKLVGMSEACLHRKSHSERRSTLK...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682